Leelyn Smith LLC Acquires 136 Shares of CME Group Inc. (NASDAQ:CME)

Leelyn Smith LLC raised its stake in CME Group Inc. (NASDAQ:CMEFree Report) by 1.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 11,395 shares of the financial services provider’s stock after buying an additional 136 shares during the quarter. Leelyn Smith LLC’s holdings in CME Group were worth $2,646,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Raymond James Financial Inc. bought a new position in shares of CME Group during the fourth quarter worth about $871,063,000. Franklin Resources Inc. raised its holdings in shares of CME Group by 70.4% in the third quarter. Franklin Resources Inc. now owns 2,427,107 shares of the financial services provider’s stock valued at $544,157,000 after purchasing an additional 1,003,119 shares during the last quarter. Capital Wealth Planning LLC lifted its position in shares of CME Group by 69.2% in the fourth quarter. Capital Wealth Planning LLC now owns 2,435,823 shares of the financial services provider’s stock worth $565,671,000 after purchasing an additional 996,498 shares in the last quarter. Egerton Capital UK LLP acquired a new position in CME Group during the fourth quarter worth $223,967,000. Finally, Canoe Financial LP grew its position in CME Group by 698.0% in the fourth quarter. Canoe Financial LP now owns 544,219 shares of the financial services provider’s stock valued at $126,384,000 after purchasing an additional 476,019 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have commented on CME. Oppenheimer boosted their price target on shares of CME Group from $258.00 to $269.00 and gave the stock an “outperform” rating in a research report on Thursday, February 13th. JPMorgan Chase & Co. upped their target price on CME Group from $209.00 to $212.00 and gave the stock an “underweight” rating in a report on Thursday, February 13th. Piper Sandler raised their price target on CME Group from $250.00 to $258.00 and gave the company an “overweight” rating in a research note on Tuesday, January 7th. Raymond James raised CME Group from a “market perform” rating to an “outperform” rating and set a $287.00 price target on the stock in a research report on Monday, March 10th. Finally, Keefe, Bruyette & Woods increased their price objective on CME Group from $256.00 to $257.00 and gave the company a “market perform” rating in a report on Friday, February 14th. Four equities research analysts have rated the stock with a sell rating, eight have given a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, CME Group presently has an average rating of “Hold” and an average price target of $238.93.

Read Our Latest Research Report on CME

CME Group Stock Performance

Shares of CME stock opened at $263.58 on Tuesday. The company has a market capitalization of $94.98 billion, a price-to-earnings ratio of 27.26, a PEG ratio of 6.76 and a beta of 0.53. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.01. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $264.95. The company has a 50-day simple moving average of $243.56 and a 200 day simple moving average of $232.93.

CME Group (NASDAQ:CMEGet Free Report) last issued its quarterly earnings data on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.46 by $0.06. CME Group had a return on equity of 13.62% and a net margin of 57.52%. On average, sell-side analysts predict that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Friday, March 7th will be given a dividend of $1.25 per share. This is a boost from CME Group’s previous quarterly dividend of $1.15. The ex-dividend date of this dividend is Friday, March 7th. This represents a $5.00 annualized dividend and a yield of 1.90%. CME Group’s dividend payout ratio (DPR) is presently 51.71%.

CME Group announced that its board has authorized a stock buyback program on Thursday, December 5th that permits the company to buyback $3.00 billion in shares. This buyback authorization permits the financial services provider to buy up to 3.4% of its shares through open market purchases. Shares buyback programs are usually a sign that the company’s leadership believes its stock is undervalued.

Insider Transactions at CME Group

In other CME Group news, insider Julie Winkler sold 11,592 shares of CME Group stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $249.17, for a total value of $2,888,378.64. Following the completion of the transaction, the insider now directly owns 21,885 shares of the company’s stock, valued at $5,453,085.45. The trade was a 34.63 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Howard J. Siegel sold 10,000 shares of the company’s stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $260.00, for a total value of $2,600,000.00. Following the sale, the director now owns 21,873 shares of the company’s stock, valued at approximately $5,686,980. The trade was a 31.37 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 27,076 shares of company stock valued at $6,871,496. 0.30% of the stock is currently owned by corporate insiders.

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Articles

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.